2022
The role of lung cancer risk and comorbidity in lung cancer screening use
Richman IB, Long JB, Poghosyan H, Sather P, Gross CP. The role of lung cancer risk and comorbidity in lung cancer screening use. Preventive Medicine Reports 2022, 30: 102006. PMID: 36203942, PMCID: PMC9530957, DOI: 10.1016/j.pmedr.2022.102006.Peer-Reviewed Original ResearchLung cancer screeningLung cancer riskDiagnostic chest CTCancer riskLow comorbidityCancer screeningChest CTGreater lung cancer riskHigher lung cancer riskLow-dose computed tomographyCancer screening useLung cancer mortalityDose computed tomographyElectronic health recordsLCS useCohort studyPatient characteristicsEligible adultsCancer mortalityScreening useComorbiditiesComputed tomographyDiagnostic CTDiagnostic imagingPatients
2020
Worry About the Future Health Issues of Smoking and Intention to Screen for Lung Cancer With Low-Dose Computed Tomography
Poghosyan H, Mello S, Robinson K, Tan A. Worry About the Future Health Issues of Smoking and Intention to Screen for Lung Cancer With Low-Dose Computed Tomography. Cancer Nursing 2020, 45: e146-e152. PMID: 34870941, PMCID: PMC8649175, DOI: 10.1097/ncc.0000000000000897.Peer-Reviewed Original ResearchConceptsIssue of smokingLung cancer screeningLow-dose computed tomographyRecommending lung cancer screeningHealth issuesBenefits of lung cancer screeningRates of lung cancer screeningCross-sectional online surveyFuture health issuesLung cancerMultivariate logistic regressionCancer screeningHealthcare providersSocioeconomic differencesEligible adultsComputed tomographyAdult smokersLogistic regressionExpressed worriesSmokingHealthLong-term prognosisSmoking historyDiagnosis of lung cancerModerately/very